162 related articles for article (PubMed ID: 38238977)
1. Prognostic Value of BAP1 Protein Expression in Uveal Melanoma.
Kennedy S; Owens S; Ivers L; Hegarty C; O'Neill V; Berenguer-Pina JJ; Horgan N; Crown J; Walsh N
Am J Surg Pathol; 2024 Mar; 48(3):329-336. PubMed ID: 38238977
[TBL] [Abstract][Full Text] [Related]
2. Piloting a Deep Learning Model for Predicting Nuclear BAP1 Immunohistochemical Expression of Uveal Melanoma from Hematoxylin-and-Eosin Sections.
Zhang H; Kalirai H; Acha-Sagredo A; Yang X; Zheng Y; Coupland SE
Transl Vis Sci Technol; 2020 Sep; 9(2):50. PubMed ID: 32953248
[TBL] [Abstract][Full Text] [Related]
3. Patterns of BAP1 protein expression provide insights into prognostic significance and the biology of uveal melanoma.
Farquhar N; Thornton S; Coupland SE; Coulson JM; Sacco JJ; Krishna Y; Heimann H; Taktak A; Cebulla CM; Abdel-Rahman MH; Kalirai H
J Pathol Clin Res; 2018 Jan; 4(1):26-38. PubMed ID: 29416875
[TBL] [Abstract][Full Text] [Related]
4. Lack of BAP1 protein expression in uveal melanoma is associated with increased metastatic risk and has utility in routine prognostic testing.
Kalirai H; Dodson A; Faqir S; Damato BE; Coupland SE
Br J Cancer; 2014 Sep; 111(7):1373-80. PubMed ID: 25058347
[TBL] [Abstract][Full Text] [Related]
5. Prognostic parameters in uveal melanoma and their association with BAP1 expression.
van Essen TH; van Pelt SI; Versluis M; Bronkhorst IH; van Duinen SG; Marinkovic M; Kroes WG; Ruivenkamp CA; Shukla S; de Klein A; Kiliç E; Harbour JW; Luyten GP; van der Velden PA; Verdijk RM; Jager MJ
Br J Ophthalmol; 2014 Dec; 98(12):1738-43. PubMed ID: 25147369
[TBL] [Abstract][Full Text] [Related]
6. Prognostic value of chromosomal imbalances, gene mutations, and BAP1 expression in uveal melanoma.
Patrone S; Maric I; Rutigliani M; Lanza F; Puntoni M; Banelli B; Rancati S; Angelini G; Amaro A; Ligorio P; Defferrari C; Castagnetta M; Bandelloni R; Mosci C; DeCensi A; Romani M; Pfeffer U; Viaggi S; Coviello DA
Genes Chromosomes Cancer; 2018 Aug; 57(8):387-400. PubMed ID: 29689622
[TBL] [Abstract][Full Text] [Related]
7. Uveal Melanoma Nuclear BRCA1-Associated Protein-1 Immunoreactivity Is an Indicator of Metastasis.
Szalai E; Wells JR; Ward L; Grossniklaus HE
Ophthalmology; 2018 Feb; 125(2):203-209. PubMed ID: 28823399
[TBL] [Abstract][Full Text] [Related]
8. BRCA-associated protein1 (BAP1) immunohistochemical stain reliability in postbrachytherapy uveal melanoma enucleation specimens.
Eiger-Moscovich M; Shields CL; Eagle RC; Milman T
Indian J Ophthalmol; 2024 May; 72(Suppl 3):S459-S467. PubMed ID: 38324631
[TBL] [Abstract][Full Text] [Related]
9. Metastatic Disease in Polyploid Uveal Melanoma Patients Is Associated With BAP1 Mutations.
Yavuzyigitoglu S; Mensink HW; Smit KN; Vaarwater J; Verdijk RM; Beverloo B; Brüggenwirth HT; van Marion R; Dubbink HJ; Paridaens D; Naus NC; de Klein A; Kiliç E;
Invest Ophthalmol Vis Sci; 2016 Apr; 57(4):2232-9. PubMed ID: 27116551
[TBL] [Abstract][Full Text] [Related]
10. Correlation of Immunocytochemistry of BRCA1-associated Protein-1 (BAP1) With Other Prognostic Markers in Uveal Melanoma.
Glasgow BJ; McCannel TA
Am J Ophthalmol; 2018 May; 189():122-126. PubMed ID: 29530782
[TBL] [Abstract][Full Text] [Related]
11. Chromosome 3 status combined with BAP1 and EIF1AX mutation profiles are associated with metastasis in uveal melanoma.
Ewens KG; Kanetsky PA; Richards-Yutz J; Purrazzella J; Shields CL; Ganguly T; Ganguly A
Invest Ophthalmol Vis Sci; 2014 Jun; 55(8):5160-7. PubMed ID: 24970262
[TBL] [Abstract][Full Text] [Related]
12. Comparing the Prognostic Value of BAP1 Mutation Pattern, Chromosome 3 Status, and BAP1 Immunohistochemistry in Uveal Melanoma.
van de Nes JA; Nelles J; Kreis S; Metz CH; Hager T; Lohmann DR; Zeschnigk M
Am J Surg Pathol; 2016 Jun; 40(6):796-805. PubMed ID: 27015033
[TBL] [Abstract][Full Text] [Related]
13. Driver Mutations in Uveal Melanoma: Associations With Gene Expression Profile and Patient Outcomes.
Decatur CL; Ong E; Garg N; Anbunathan H; Bowcock AM; Field MG; Harbour JW
JAMA Ophthalmol; 2016 Jul; 134(7):728-33. PubMed ID: 27123562
[TBL] [Abstract][Full Text] [Related]
14. The Potential Role of Selected miRNA in Uveal Melanoma Primary Tumors as Early Biomarkers of Disease Progression.
Wróblewska JP; Lach MS; Ustaszewski A; Kulcenty K; Ibbs M; Jagiełło I; Suchorska WM; Marszałek A
Genes (Basel); 2020 Mar; 11(3):. PubMed ID: 32131485
[TBL] [Abstract][Full Text] [Related]
15. BAP1 germline mutation in two first grade family members with uveal melanoma.
Maerker DA; Zeschnigk M; Nelles J; Lohmann DR; Worm K; Bosserhoff AK; Krupar R; Jägle H
Br J Ophthalmol; 2014 Feb; 98(2):224-7. PubMed ID: 24187051
[TBL] [Abstract][Full Text] [Related]
16. Prognostic impact of chromosomal aberrations and GNAQ, GNA11 and BAP1 mutations in uveal melanoma.
Staby KM; Gravdal K; Mørk SJ; Heegaard S; Vintermyr OK; Krohn J
Acta Ophthalmol; 2018 Feb; 96(1):31-38. PubMed ID: 28444874
[TBL] [Abstract][Full Text] [Related]
17. Correlation between BAP1 Localization, Driver Mutations, and Patient Survival in Uveal Melanoma.
Cole YC; Zhang YZ; Gallo B; Januszewski AP; Nastase A; Essex DJ; Thaung CMH; Cohen VML; Sagoo MS; Bowcock AM
Cancers (Basel); 2022 Aug; 14(17):. PubMed ID: 36077643
[TBL] [Abstract][Full Text] [Related]
18. Altered Nuclear Expression of the Deubiquitylase BAP1 Cannot be Used as a Prognostic Marker for Canine Melanoma.
Jama N; Farquhar N; Butt Z; Coupland SE; Sacco JJ; Scase T; Fielding AB; Coulson JM; Kalirai H; Killick DR
J Comp Pathol; 2018 Jul; 162():50-58. PubMed ID: 30060843
[TBL] [Abstract][Full Text] [Related]
19. Clinical significance of immunohistochemistry for detection of BAP1 mutations in uveal melanoma.
Koopmans AE; Verdijk RM; Brouwer RW; van den Bosch TP; van den Berg MM; Vaarwater J; Kockx CE; Paridaens D; Naus NC; Nellist M; van IJcken WF; Kiliç E; de Klein A
Mod Pathol; 2014 Oct; 27(10):1321-30. PubMed ID: 24633195
[TBL] [Abstract][Full Text] [Related]
20. Analysis of uveal melanomas and paired constitutional DNA for exclusion of a BAP1-tumor predisposition syndrome.
Abbassi YA; Le Guin C; Bornfeld N; Bechrakis NE; Zeschnigk M; Lohmann DR
Fam Cancer; 2023 Apr; 22(2):193-202. PubMed ID: 35920959
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]